cell-device combo
Vertex Lays Off 125 Staffers, Shrinks Rhode Island Campus After Diabetes Therapy Setback
Vertex Pharmaceuticals; layoffs; Rhode Island; diabetes therapy; VX-264; cell-device combo; clinical trial failure; facility consolidation
Actionable Insights Powered by AI
Vertex Pharmaceuticals; layoffs; Rhode Island; diabetes therapy; VX-264; cell-device combo; clinical trial failure; facility consolidation